564 related articles for article (PubMed ID: 1078825)
1. Complement fixation by rheumatoid factor.
Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
[TBL] [Abstract][Full Text] [Related]
2. A study of complement fixation by rheumatoid factor using a haemolytic assay system.
Taylor-Upsahl MM; Johnson PM; Mellbye OJ; Natvig JB
Clin Exp Immunol; 1977 May; 28(2):204-11. PubMed ID: 872448
[TBL] [Abstract][Full Text] [Related]
3. Effect of rheumatoid factor on complement-mediated phagocytosis.
McDuffie FC; Brumfield HW
J Clin Invest; 1972 Dec; 51(12):3007-14. PubMed ID: 4640945
[TBL] [Abstract][Full Text] [Related]
4. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
5. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
[TBL] [Abstract][Full Text] [Related]
6. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
7. Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration.
Schmid FR; Roitt IM; Rocha MJ
J Exp Med; 1970 Oct; 132(4):673-93. PubMed ID: 5508376
[TBL] [Abstract][Full Text] [Related]
8. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
9. Complement activation by 19S IgM rheumatoid factor: relationship to disease activity in rheumatoid arthritis.
Robbins DL; Fiegal DW; Leek JC; Shapiro R; Wiesner K
J Rheumatol; 1986 Feb; 13(1):33-8. PubMed ID: 3701741
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor.
Davidson A; Lopez J; Sun D; Prus D
J Immunol; 1992 Jun; 148(12):3873-8. PubMed ID: 1376343
[TBL] [Abstract][Full Text] [Related]
11. Kinetic measurement of the interaction of rheumatoid factor with IgG-coated latex particles and the influence of the first component of human complement.
Hällgren R
Clin Exp Immunol; 1980 Jan; 39(1):154-63. PubMed ID: 6771071
[TBL] [Abstract][Full Text] [Related]
12. Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C gamma 2-C gamma 3 interface region contains the major determinants.
Sasso EH; Barber CV; Nardella FA; Yount WJ; Mannik M
J Immunol; 1988 May; 140(9):3098-107. PubMed ID: 2452199
[TBL] [Abstract][Full Text] [Related]
13. Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis.
Weisman M; Zvaifler N
J Clin Invest; 1975 Sep; 56(3):725-39. PubMed ID: 169295
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring low molecular weight IgM in patients with rheumatoid arthritis, systemic lupus erythematosus and macroglobulinemia. I. Purification and immunologic studies.
Harisdangkul V; McDougal JS; Knapp M; Christian CL
J Immunol; 1975 Jul; 115(1):216-22. PubMed ID: 807624
[TBL] [Abstract][Full Text] [Related]
15. The internal image of IgG in cross-reactive anti-idiotypic antibodies against human rheumatoid factors.
Fong S; Gilbertson TA; Carson DA
J Immunol; 1983 Aug; 131(2):719-24. PubMed ID: 6863929
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Clq binding activity by IgM rheumatoid factor.
Zilberfarb JL; Andrews BS; Young AC; Davis JS
J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
[TBL] [Abstract][Full Text] [Related]
17. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
Doekes G; Schouten J; Cats A; Daha MR
Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
[TBL] [Abstract][Full Text] [Related]
18. A highly conserved determinant on human rheumatoid factor idiotypes defined by a mouse monoclonal antibody.
Pasquali JL; Urlacher A; Storck D
Eur J Immunol; 1983 Mar; 13(3):197-201. PubMed ID: 6187582
[TBL] [Abstract][Full Text] [Related]
19. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
Wagner T; Abraham G; Baum J
J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
[TBL] [Abstract][Full Text] [Related]
20. Serum IgG and IgM rheumatoid factors and complement activation in extraarticular rheumatoid disease.
Jakle C; Feigal DW; Robbins DL; Shapiro R; Wiesner K
J Rheumatol; 1985 Apr; 12(2):227-32. PubMed ID: 3875718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
